iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
According to iSpecimen Inc.'s latest financial reports the company's current revenue (TTM) is $9.93 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
---|---|---|---|---|---|
2023 | $9.93 M | $5.11 M | $-9,103,720 | $-11,099,488 | $-11,099,488 |
2022 | $10.4 M | $5.65 M | $-8,801,758 | $-10,245,922 | $-9,040,723 |
2021 | $11.14 M | $5.89 M | $-5,855,136 | $-8,961,815 | $-10,015,968 |
2020 | $8.18 M | $4.6 M | $-1,735,606 | $-4,652,084 | $-6,758,533 |
2019 | $4.3 M | $2.17 M | $-2,524,634 | $-4,884,050 | $-4,727,050 |
2018 | $4.39 M | $2.03 M | $-3,789,899 | $-5,474,052 | $-5,347,052 |